Ad  RAD Intel

The Company Fixing Ads Isn't Public Yet – But Insiders Are Investing

You've seen them. The cringey, mistargeted, and downright WTF ads. You sit there wondering why brands are spending billions on content that just leaves you questioning your entire algorithmic existence after seeing it.

RAD Intel is teaching brands - with proprietary tech - how to read the room. Their AI helps brands understand why content works, who it actually resonates with, and what to say next. RAD analyzes real-time audience behavior and predicts what will convert, so brands can stop guessing and start making ads that actually land.

And it's already in serious demand. Fortune 1000 brands like Hasbro, Sweetgreen, Skechers, and MGM are using RAD Intel to level up their marketing - and getting up to 3.5x better results. With $37M+ raised and a valuation that's jumped from $5M to $85M*, it's a bit of a shock that RAD Intel is still pre-IPO. Shares are just $0.60, and investors from Meta, Google, Amazon, and Fidelity Ventures are already in.

So check them out now and get in on the action before then, lest you get stuck in the "I almost invested" cycle of regret.

👉 Click here to secure your shares


DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.

CVS to close some pharmacies within Target stores

(Reuters) – CVS Health said on Thursday it will close some pharmacies that operate inside Target stores during the first several months of the year.

The closures will begin in February and be completed by the end of April, a company spokesperson said. Prescriptions will be transferred to a nearby CVS Pharmacy prior to closing, the spokesperson added.

U.S. pharmacy chains including rival Walgreens Boots Alliance have been implementing cost cuts in an effort to tackle decreased spending by inflation-weary consumers and intense competition.

The pharmacy closures are “based on our evaluation of changes in population, consumer buying patterns and future health needs,” CVS said.

The spokesperson declined to comment on locations impacted by the move, but said the employees affected by the closures will be offered comparable roles within the company.

CVS in 2015 bought Target’s pharmacies and clinics in a $1.9 billion deal adding about 1,660 pharmacies in the process.

The healthcare conglomerate, which now operates more than 9,000 retail pharmacies in the United States, also includes one of the largest U.S. pharmacy benefit managers and the Aetna health insurer.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shweta Agarwal and Maju Samuel)

tagreuters.com2024binary_LYNXMPEK0A0ZQ-VIEWIMAGE